Global Personalized Medicines In Oncology Industry Research Report, Competitive Landscape, Market Size, Regional Status and Prospect
The report combines extensive quantitative analysis and exhaustive qualitative analysis, ranges from a macro overview of the total market size, industry chain, and market dynamics to micro details of segment markets by type, application and region, and, as a result, provides a holistic view of, as well as a deep insight into the Personalized Medicines In Oncology market covering all its essential aspects.
For the competitive landscape, the report also introduces players in the industry from the perspective of the market share, concentration ratio, etc., and describes the leading companies in detail, with which the readers can get a better idea of their competitors and acquire an in-depth understanding of the competitive situation. Further, mergers & acquisitions, emerging market trends, the impact of COVID-19, and regional conflicts will all be considered.
In a nutshell, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the market in any manner.
Key players in the global Personalized Medicines In Oncology market are covered in Chapter 9:
Genomic Health, Inc.(Exact Sciences)
Illumina
Caris Life Sciences
Cypher Genomics(Human Longevity, Inc.)
Biotheranostics
Life Technologies Corporation(Thermo Fisher Scientific)
Ariana Pharma
Fulgent Genetics
DNA Link
In Chapter 5 and Chapter 7.3, based on types, the Personalized Medicines In Oncology market from 2017 to 2027 is primarily split into:
Molecular Oncopathology
Genome Diagnostics
Radiation Therapy
Oncology Testing
Chemotherapy
Others
In Chapter 6 and Chapter 7.4, based on applications, the Personalized Medicines In Oncology market from 2017 to 2027 covers:
Research Centers
Governmental Institutions
Hospitals
Clinical Centers
Others
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historical data and forecast (2017-2027) of the following regions are covered in Chapter 4 and Chapter 7:
United States
Europe
China
Japan
India
Southeast Asia
Latin America
Middle East and Africa
Client Focus
1. Does this report consider the impact of COVID-19 and the Russia-Ukraine war on the Personalized Medicines In Oncology market?
Yes. As the COVID-19 and the Russia-Ukraine war are profoundly affecting the global supply chain relationship and raw material price system, we have definitely taken them into consideration throughout the research, and in Chapters 1.7, 2.7, 4.X.1, 7.5, 8.7, we elaborate at full length on the impact of the pandemic and the war on the Personalized Medicines In Oncology Industry.
2. How do you determine the list of the key players included in the report?
With the aim of clearly revealing the competitive situation of the industry, we concretely analyze not only the leading enterprises that have a voice on a global scale, but also the regional small and medium-sized companies that play key roles and have plenty of potential growth.
Please find the key player list in Summary.
3. What are your main data sources?
Both Primary and Secondary data sources are being used while compiling the report.
Primary sources include extensive interviews of key opinion leaders and industry experts (such as experienced front-line staff, directors, CEOs, and marketing executives), downstream distributors, as well as end-users.
Secondary sources include the research of the annual and financial reports of the top companies, public files, new journals, etc. We also cooperate with some third-party databases.
Please find a more complete list of data sources in Chapters 11.2.1 & 11.2.2.
4. Can I modify the scope of the report and customize it to suit my requirements?
Yes. Customized requirements of multi-dimensional, deep-level and high-quality can help our customers precisely grasp market opportunities, effortlessly confront market challenges, properly formulate market strategies and act promptly, thus to win them sufficient time and space for market competition.
Outline
Chapter 1 mainly defines the market scope and introduces the macro overview of the industry, with an executive summary of different market segments ((by type, application, region, etc.), including the definition, market size, and trend of each market segment.
Chapter 2 provides a qualitative analysis of the current status and future trends of the market. Industry Entry Barriers, market drivers, market challenges, emerging markets, consumer preference analysis, together with the impact of the COVID-19 outbreak will all be thoroughly explained.
Chapter 3 analyzes the current competitive situation of the market by providing data regarding the players, including their sales volume and revenue with corresponding market shares, price and gross margin. In addition, information about market concentration ratio, mergers, acquisitions, and expansion plans will also be covered.
Chapter 4 focuses on the regional market, presenting detailed data (i.e., sales volume, revenue, price, gross margin) of the most representative regions and countries in the world.
Chapter 5 provides the analysis of various market segments according to product types, covering sales volume, revenue along with market share and growth rate, plus the price analysis of each type.
Chapter 6 shows the breakdown data of different applications, including the consumption and revenue with market share and growth rate, with the aim of helping the readers to take a close-up look at the downstream market.
Chapter 7 provides a combination of quantitative and qualitative analyses of the market size and development trends in the next five years. The forecast information of the whole, as well as the breakdown market, offers the readers a chance to look into the future of the industry.
Chapter 8 is the analysis of the whole market industrial chain, covering key raw materials suppliers and price analysis, manufacturing cost structure analysis, alternative product analysis, also providing information on major distributors, downstream buyers, and the impact of COVID-19 pandemic.
Chapter 9 shares a list of the key players in the market, together with their basic information, product profiles, market performance (i.e., sales volume, price, revenue, gross margin), recent development, SWOT analysis, etc.
Chapter 10 is the conclusion of the report which helps the readers to sum up the main findings and points.
Chapter 11 introduces the market research methods and data sources.
Years considered for this report:
Historical Years: 2017-2021
Base Year: 2021
Estimated Year: 2022
Forecast Period: 2022-2027
1 PERSONALIZED MEDICINES IN ONCOLOGY MARKET OVERVIEW
1.1 Product Overview and Scope of Personalized Medicines In Oncology Market
1.2 Personalized Medicines In Oncology Market Segment by Type
1.2.1 Global Personalized Medicines In Oncology Market Sales Volume and CAGR (%) Comparison by Type (2017-2027)
1.3 Global Personalized Medicines In Oncology Market Segment by Application
1.3.1 Personalized Medicines In Oncology Market Consumption (Sales Volume) Comparison by Application (2017-2027)
1.4 Global Personalized Medicines In Oncology Market, Region Wise (2017-2027)
1.4.1 Global Personalized Medicines In Oncology Market Size (Revenue) and CAGR (%) Comparison by Region (2017-2027)
1.4.2 United States Personalized Medicines In Oncology Market Status and Prospect (2017-2027)
1.4.3 Europe Personalized Medicines In Oncology Market Status and Prospect (2017-2027)
1.4.4 China Personalized Medicines In Oncology Market Status and Prospect (2017-2027)
1.4.5 Japan Personalized Medicines In Oncology Market Status and Prospect (2017-2027)
1.4.6 India Personalized Medicines In Oncology Market Status and Prospect (2017-2027)
1.4.7 Southeast Asia Personalized Medicines In Oncology Market Status and Prospect (2017-2027)
1.4.8 Latin America Personalized Medicines In Oncology Market Status and Prospect (2017-2027)
1.4.9 Middle East and Africa Personalized Medicines In Oncology Market Status and Prospect (2017-2027)
1.5 Global Market Size of Personalized Medicines In Oncology (2017-2027)
1.5.1 Global Personalized Medicines In Oncology Market Revenue Status and Outlook (2017-2027)
1.5.2 Global Personalized Medicines In Oncology Market Sales Volume Status and Outlook (2017-2027)
1.6 Global Macroeconomic Analysis
1.7 The impact of the Russia-Ukraine war on the Personalized Medicines In Oncology Market
2 INDUSTRY OUTLOOK
2.1 Personalized Medicines In Oncology Industry Technology Status and Trends
2.2 Industry Entry Barriers
2.2.1 Analysis of Financial Barriers
2.2.2 Analysis of Technical Barriers
2.2.3 Analysis of Talent Barriers
2.2.4 Analysis of Brand Barrier
2.3 Personalized Medicines In Oncology Market Drivers Analysis
2.4 Personalized Medicines In Oncology Market Challenges Analysis
2.5 Emerging Market Trends
2.6 Consumer Preference Analysis
2.7 Personalized Medicines In Oncology Industry Development Trends under COVID-19 Outbreak
2.7.1 Global COVID-19 Status Overview
2.7.2 Influence of COVID-19 Outbreak on Personalized Medicines In Oncology Industry Development
3 GLOBAL PERSONALIZED MEDICINES IN ONCOLOGY MARKET LANDSCAPE BY PLAYER
3.1 Global Personalized Medicines In Oncology Sales Volume and Share by Player (2017-2022)
3.2 Global Personalized Medicines In Oncology Revenue and Market Share by Player (2017-2022)
3.3 Global Personalized Medicines In Oncology Average Price by Player (2017-2022)
3.4 Global Personalized Medicines In Oncology Gross Margin by Player (2017-2022)
3.5 Personalized Medicines In Oncology Market Competitive Situation and Trends
3.5.1 Personalized Medicines In Oncology Market Concentration Rate
3.5.2 Personalized Medicines In Oncology Market Share of Top 3 and Top 6 Players
3.5.3 Mergers & Acquisitions, Expansion
4 GLOBAL PERSONALIZED MEDICINES IN ONCOLOGY SALES VOLUME AND REVENUE REGION WISE (2017-2022)
4.1 Global Personalized Medicines In Oncology Sales Volume and Market Share, Region Wise (2017-2022)
4.2 Global Personalized Medicines In Oncology Revenue and Market Share, Region Wise (2017-2022)
4.3 Global Personalized Medicines In Oncology Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4 United States Personalized Medicines In Oncology Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4.1 United States Personalized Medicines In Oncology Market Under COVID-19
4.5 Europe Personalized Medicines In Oncology Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.5.1 Europe Personalized Medicines In Oncology Market Under COVID-19
4.6 China Personalized Medicines In Oncology Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.6.1 China Personalized Medicines In Oncology Market Under COVID-19
4.7 Japan Personalized Medicines In Oncology Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.7.1 Japan Personalized Medicines In Oncology Market Under COVID-19
4.8 India Personalized Medicines In Oncology Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.8.1 India Personalized Medicines In Oncology Market Under COVID-19
4.9 Southeast Asia Personalized Medicines In Oncology Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.9.1 Southeast Asia Personalized Medicines In Oncology Market Under COVID-19
4.10 Latin America Personalized Medicines In Oncology Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.10.1 Latin America Personalized Medicines In Oncology Market Under COVID-19
4.11 Middle East and Africa Personalized Medicines In Oncology Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.11.1 Middle East and Africa Personalized Medicines In Oncology Market Under COVID-19
5 GLOBAL PERSONALIZED MEDICINES IN ONCOLOGY SALES VOLUME, REVENUE, PRICE TREND BY TYPE
5.1 Global Personalized Medicines In Oncology Sales Volume and Market Share by Type (2017-2022)
5.2 Global Personalized Medicines In Oncology Revenue and Market Share by Type (2017-2022)
5.3 Global Personalized Medicines In Oncology Price by Type (2017-2022)
5.4 Global Personalized Medicines In Oncology Sales Volume, Revenue and Growth Rate by Type (2017-2022)
5.4.1 Global Personalized Medicines In Oncology Sales Volume, Revenue and Growth Rate of Molecular Oncopathology (2017-2022)
5.4.2 Global Personalized Medicines In Oncology Sales Volume, Revenue and Growth Rate of Genome Diagnostics (2017-2022)
5.4.3 Global Personalized Medicines In Oncology Sales Volume, Revenue and Growth Rate of Radiation Therapy (2017-2022)
5.4.4 Global Personalized Medicines In Oncology Sales Volume, Revenue and Growth Rate of Oncology Testing (2017-2022)
5.4.5 Global Personalized Medicines In Oncology Sales Volume, Revenue and Growth Rate of Chemotherapy (2017-2022)
5.4.6 Global Personalized Medicines In Oncology Sales Volume, Revenue and Growth Rate of Others (2017-2022)
6 GLOBAL PERSONALIZED MEDICINES IN ONCOLOGY MARKET ANALYSIS BY APPLICATION
6.1 Global Personalized Medicines In Oncology Consumption and Market Share by Application (2017-2022)
6.2 Global Personalized Medicines In Oncology Consumption Revenue and Market Share by Application (2017-2022)
6.3 Global Personalized Medicines In Oncology Consumption and Growth Rate by Application (2017-2022)
6.3.1 Global Personalized Medicines In Oncology Consumption and Growth Rate of Research Centers (2017-2022)
6.3.2 Global Personalized Medicines In Oncology Consumption and Growth Rate of Governmental Institutions (2017-2022)
6.3.3 Global Personalized Medicines In Oncology Consumption and Growth Rate of Hospitals (2017-2022)
6.3.4 Global Personalized Medicines In Oncology Consumption and Growth Rate of Clinical Centers (2017-2022)
6.3.5 Global Personalized Medicines In Oncology Consumption and Growth Rate of Others (2017-2022)
7 GLOBAL PERSONALIZED MEDICINES IN ONCOLOGY MARKET FORECAST (2022-2027)
7.1 Global Personalized Medicines In Oncology Sales Volume, Revenue Forecast (2022-2027)
7.1.1 Global Personalized Medicines In Oncology Sales Volume and Growth Rate Forecast (2022-2027)
7.1.2 Global Personalized Medicines In Oncology Revenue and Growth Rate Forecast (2022-2027)
7.1.3 Global Personalized Medicines In Oncology Price and Trend Forecast (2022-2027)
7.2 Global Personalized Medicines In Oncology Sales Volume and Revenue Forecast, Region Wise (2022-2027)
7.2.1 United States Personalized Medicines In Oncology Sales Volume and Revenue Forecast (2022-2027)
7.2.2 Europe Personalized Medicines In Oncology Sales Volume and Revenue Forecast (2022-2027)
7.2.3 China Personalized Medicines In Oncology Sales Volume and Revenue Forecast (2022-2027)
7.2.4 Japan Personalized Medicines In Oncology Sales Volume and Revenue Forecast (2022-2027)
7.2.5 India Personalized Medicines In Oncology Sales Volume and Revenue Forecast (2022-2027)
7.2.6 Southeast Asia Personalized Medicines In Oncology Sales Volume and Revenue Forecast (2022-2027)
7.2.7 Latin America Personalized Medicines In Oncology Sales Volume and Revenue Forecast (2022-2027)
7.2.8 Middle East and Africa Personalized Medicines In Oncology Sales Volume and Revenue Forecast (2022-2027)
7.3 Global Personalized Medicines In Oncology Sales Volume, Revenue and Price Forecast by Type (2022-2027)
7.3.1 Global Personalized Medicines In Oncology Revenue and Growth Rate of Molecular Oncopathology (2022-2027)
7.3.2 Global Personalized Medicines In Oncology Revenue and Growth Rate of Genome Diagnostics (2022-2027)
7.3.3 Global Personalized Medicines In Oncology Revenue and Growth Rate of Radiation Therapy (2022-2027)
7.3.4 Global Personalized Medicines In Oncology Revenue and Growth Rate of Oncology Testing (2022-2027)
7.3.5 Global Personalized Medicines In Oncology Revenue and Growth Rate of Chemotherapy (2022-2027)
7.3.6 Global Personalized Medicines In Oncology Revenue and Growth Rate of Others (2022-2027)
7.4 Global Personalized Medicines In Oncology Consumption Forecast by Application (2022-2027)
7.4.1 Global Personalized Medicines In Oncology Consumption Value and Growth Rate of Research Centers(2022-2027)
7.4.2 Global Personalized Medicines In Oncology Consumption Value and Growth Rate of Governmental Institutions(2022-2027)
7.4.3 Global Personalized Medicines In Oncology Consumption Value and Growth Rate of Hospitals(2022-2027)
7.4.4 Global Personalized Medicines In Oncology Consumption Value and Growth Rate of Clinical Centers(2022-2027)
7.4.5 Global Personalized Medicines In Oncology Consumption Value and Growth Rate of Others(2022-2027)
7.5 Personalized Medicines In Oncology Market Forecast Under COVID-19
8 PERSONALIZED MEDICINES IN ONCOLOGY MARKET UPSTREAM AND DOWNSTREAM ANALYSIS
8.1 Personalized Medicines In Oncology Industrial Chain Analysis
8.2 Key Raw Materials Suppliers and Price Analysis
8.3 Manufacturing Cost Structure Analysis
8.3.1 Labor Cost Analysis
8.3.2 Energy Costs Analysis
8.3.3 R&D Costs Analysis
8.4 Alternative Product Analysis
8.5 Major Distributors of Personalized Medicines In Oncology Analysis
8.6 Major Downstream Buyers of Personalized Medicines In Oncology Analysis
8.7 Impact of COVID-19 and the Russia-Ukraine war on the Upstream and Downstream in the Personalized Medicines In Oncology Industry
9 PLAYERS PROFILES
9.1 Genomic Health, Inc.(Exact Sciences)
9.1.1 Genomic Health, Inc.(Exact Sciences) Basic Information, Manufacturing Base, Sales Region and Competitors
9.1.2 Personalized Medicines In Oncology Product Profiles, Application and Specification
9.1.3 Genomic Health, Inc.(Exact Sciences) Market Performance (2017-2022)
9.1.4 Recent Development
9.1.5 SWOT Analysis
9.2 Illumina
9.2.1 Illumina Basic Information, Manufacturing Base, Sales Region and Competitors
9.2.2 Personalized Medicines In Oncology Product Profiles, Application and Specification
9.2.3 Illumina Market Performance (2017-2022)
9.2.4 Recent Development
9.2.5 SWOT Analysis
9.3 Caris Life Sciences
9.3.1 Caris Life Sciences Basic Information, Manufacturing Base, Sales Region and Competitors
9.3.2 Personalized Medicines In Oncology Product Profiles, Application and Specification
9.3.3 Caris Life Sciences Market Performance (2017-2022)
9.3.4 Recent Development
9.3.5 SWOT Analysis
9.4 Cypher Genomics(Human Longevity, Inc.)
9.4.1 Cypher Genomics(Human Longevity, Inc.) Basic Information, Manufacturing Base, Sales Region and Competitors
9.4.2 Personalized Medicines In Oncology Product Profiles, Application and Specification
9.4.3 Cypher Genomics(Human Longevity, Inc.) Market Performance (2017-2022)
9.4.4 Recent Development
9.4.5 SWOT Analysis
9.5 Biotheranostics
9.5.1 Biotheranostics Basic Information, Manufacturing Base, Sales Region and Competitors
9.5.2 Personalized Medicines In Oncology Product Profiles, Application and Specification
9.5.3 Biotheranostics Market Performance (2017-2022)
9.5.4 Recent Development
9.5.5 SWOT Analysis
9.6 Life Technologies Corporation(Thermo Fisher Scientific)
9.6.1 Life Technologies Corporation(Thermo Fisher Scientific) Basic Information, Manufacturing Base, Sales Region and Competitors
9.6.2 Personalized Medicines In Oncology Product Profiles, Application and Specification
9.6.3 Life Technologies Corporation(Thermo Fisher Scientific) Market Performance (2017-2022)
9.6.4 Recent Development
9.6.5 SWOT Analysis
9.7 Ariana Pharma
9.7.1 Ariana Pharma Basic Information, Manufacturing Base, Sales Region and Competitors
9.7.2 Personalized Medicines In Oncology Product Profiles, Application and Specification
9.7.3 Ariana Pharma Market Performance (2017-2022)
9.7.4 Recent Development
9.7.5 SWOT Analysis
9.8 Fulgent Genetics
9.8.1 Fulgent Genetics Basic Information, Manufacturing Base, Sales Region and Competitors
9.8.2 Personalized Medicines In Oncology Product Profiles, Application and Specification
9.8.3 Fulgent Genetics Market Performance (2017-2022)
9.8.4 Recent Development
9.8.5 SWOT Analysis
9.9 DNA Link
9.9.1 DNA Link Basic Information, Manufacturing Base, Sales Region and Competitors
9.9.2 Personalized Medicines In Oncology Product Profiles, Application and Specification
9.9.3 DNA Link Market Performance (2017-2022)
9.9.4 Recent Development
9.9.5 SWOT Analysis
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Data Source
1.1 Product Overview and Scope of Personalized Medicines In Oncology Market
1.2 Personalized Medicines In Oncology Market Segment by Type
1.2.1 Global Personalized Medicines In Oncology Market Sales Volume and CAGR (%) Comparison by Type (2017-2027)
1.3 Global Personalized Medicines In Oncology Market Segment by Application
1.3.1 Personalized Medicines In Oncology Market Consumption (Sales Volume) Comparison by Application (2017-2027)
1.4 Global Personalized Medicines In Oncology Market, Region Wise (2017-2027)
1.4.1 Global Personalized Medicines In Oncology Market Size (Revenue) and CAGR (%) Comparison by Region (2017-2027)
1.4.2 United States Personalized Medicines In Oncology Market Status and Prospect (2017-2027)
1.4.3 Europe Personalized Medicines In Oncology Market Status and Prospect (2017-2027)
1.4.4 China Personalized Medicines In Oncology Market Status and Prospect (2017-2027)
1.4.5 Japan Personalized Medicines In Oncology Market Status and Prospect (2017-2027)
1.4.6 India Personalized Medicines In Oncology Market Status and Prospect (2017-2027)
1.4.7 Southeast Asia Personalized Medicines In Oncology Market Status and Prospect (2017-2027)
1.4.8 Latin America Personalized Medicines In Oncology Market Status and Prospect (2017-2027)
1.4.9 Middle East and Africa Personalized Medicines In Oncology Market Status and Prospect (2017-2027)
1.5 Global Market Size of Personalized Medicines In Oncology (2017-2027)
1.5.1 Global Personalized Medicines In Oncology Market Revenue Status and Outlook (2017-2027)
1.5.2 Global Personalized Medicines In Oncology Market Sales Volume Status and Outlook (2017-2027)
1.6 Global Macroeconomic Analysis
1.7 The impact of the Russia-Ukraine war on the Personalized Medicines In Oncology Market
2 INDUSTRY OUTLOOK
2.1 Personalized Medicines In Oncology Industry Technology Status and Trends
2.2 Industry Entry Barriers
2.2.1 Analysis of Financial Barriers
2.2.2 Analysis of Technical Barriers
2.2.3 Analysis of Talent Barriers
2.2.4 Analysis of Brand Barrier
2.3 Personalized Medicines In Oncology Market Drivers Analysis
2.4 Personalized Medicines In Oncology Market Challenges Analysis
2.5 Emerging Market Trends
2.6 Consumer Preference Analysis
2.7 Personalized Medicines In Oncology Industry Development Trends under COVID-19 Outbreak
2.7.1 Global COVID-19 Status Overview
2.7.2 Influence of COVID-19 Outbreak on Personalized Medicines In Oncology Industry Development
3 GLOBAL PERSONALIZED MEDICINES IN ONCOLOGY MARKET LANDSCAPE BY PLAYER
3.1 Global Personalized Medicines In Oncology Sales Volume and Share by Player (2017-2022)
3.2 Global Personalized Medicines In Oncology Revenue and Market Share by Player (2017-2022)
3.3 Global Personalized Medicines In Oncology Average Price by Player (2017-2022)
3.4 Global Personalized Medicines In Oncology Gross Margin by Player (2017-2022)
3.5 Personalized Medicines In Oncology Market Competitive Situation and Trends
3.5.1 Personalized Medicines In Oncology Market Concentration Rate
3.5.2 Personalized Medicines In Oncology Market Share of Top 3 and Top 6 Players
3.5.3 Mergers & Acquisitions, Expansion
4 GLOBAL PERSONALIZED MEDICINES IN ONCOLOGY SALES VOLUME AND REVENUE REGION WISE (2017-2022)
4.1 Global Personalized Medicines In Oncology Sales Volume and Market Share, Region Wise (2017-2022)
4.2 Global Personalized Medicines In Oncology Revenue and Market Share, Region Wise (2017-2022)
4.3 Global Personalized Medicines In Oncology Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4 United States Personalized Medicines In Oncology Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4.1 United States Personalized Medicines In Oncology Market Under COVID-19
4.5 Europe Personalized Medicines In Oncology Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.5.1 Europe Personalized Medicines In Oncology Market Under COVID-19
4.6 China Personalized Medicines In Oncology Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.6.1 China Personalized Medicines In Oncology Market Under COVID-19
4.7 Japan Personalized Medicines In Oncology Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.7.1 Japan Personalized Medicines In Oncology Market Under COVID-19
4.8 India Personalized Medicines In Oncology Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.8.1 India Personalized Medicines In Oncology Market Under COVID-19
4.9 Southeast Asia Personalized Medicines In Oncology Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.9.1 Southeast Asia Personalized Medicines In Oncology Market Under COVID-19
4.10 Latin America Personalized Medicines In Oncology Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.10.1 Latin America Personalized Medicines In Oncology Market Under COVID-19
4.11 Middle East and Africa Personalized Medicines In Oncology Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.11.1 Middle East and Africa Personalized Medicines In Oncology Market Under COVID-19
5 GLOBAL PERSONALIZED MEDICINES IN ONCOLOGY SALES VOLUME, REVENUE, PRICE TREND BY TYPE
5.1 Global Personalized Medicines In Oncology Sales Volume and Market Share by Type (2017-2022)
5.2 Global Personalized Medicines In Oncology Revenue and Market Share by Type (2017-2022)
5.3 Global Personalized Medicines In Oncology Price by Type (2017-2022)
5.4 Global Personalized Medicines In Oncology Sales Volume, Revenue and Growth Rate by Type (2017-2022)
5.4.1 Global Personalized Medicines In Oncology Sales Volume, Revenue and Growth Rate of Molecular Oncopathology (2017-2022)
5.4.2 Global Personalized Medicines In Oncology Sales Volume, Revenue and Growth Rate of Genome Diagnostics (2017-2022)
5.4.3 Global Personalized Medicines In Oncology Sales Volume, Revenue and Growth Rate of Radiation Therapy (2017-2022)
5.4.4 Global Personalized Medicines In Oncology Sales Volume, Revenue and Growth Rate of Oncology Testing (2017-2022)
5.4.5 Global Personalized Medicines In Oncology Sales Volume, Revenue and Growth Rate of Chemotherapy (2017-2022)
5.4.6 Global Personalized Medicines In Oncology Sales Volume, Revenue and Growth Rate of Others (2017-2022)
6 GLOBAL PERSONALIZED MEDICINES IN ONCOLOGY MARKET ANALYSIS BY APPLICATION
6.1 Global Personalized Medicines In Oncology Consumption and Market Share by Application (2017-2022)
6.2 Global Personalized Medicines In Oncology Consumption Revenue and Market Share by Application (2017-2022)
6.3 Global Personalized Medicines In Oncology Consumption and Growth Rate by Application (2017-2022)
6.3.1 Global Personalized Medicines In Oncology Consumption and Growth Rate of Research Centers (2017-2022)
6.3.2 Global Personalized Medicines In Oncology Consumption and Growth Rate of Governmental Institutions (2017-2022)
6.3.3 Global Personalized Medicines In Oncology Consumption and Growth Rate of Hospitals (2017-2022)
6.3.4 Global Personalized Medicines In Oncology Consumption and Growth Rate of Clinical Centers (2017-2022)
6.3.5 Global Personalized Medicines In Oncology Consumption and Growth Rate of Others (2017-2022)
7 GLOBAL PERSONALIZED MEDICINES IN ONCOLOGY MARKET FORECAST (2022-2027)
7.1 Global Personalized Medicines In Oncology Sales Volume, Revenue Forecast (2022-2027)
7.1.1 Global Personalized Medicines In Oncology Sales Volume and Growth Rate Forecast (2022-2027)
7.1.2 Global Personalized Medicines In Oncology Revenue and Growth Rate Forecast (2022-2027)
7.1.3 Global Personalized Medicines In Oncology Price and Trend Forecast (2022-2027)
7.2 Global Personalized Medicines In Oncology Sales Volume and Revenue Forecast, Region Wise (2022-2027)
7.2.1 United States Personalized Medicines In Oncology Sales Volume and Revenue Forecast (2022-2027)
7.2.2 Europe Personalized Medicines In Oncology Sales Volume and Revenue Forecast (2022-2027)
7.2.3 China Personalized Medicines In Oncology Sales Volume and Revenue Forecast (2022-2027)
7.2.4 Japan Personalized Medicines In Oncology Sales Volume and Revenue Forecast (2022-2027)
7.2.5 India Personalized Medicines In Oncology Sales Volume and Revenue Forecast (2022-2027)
7.2.6 Southeast Asia Personalized Medicines In Oncology Sales Volume and Revenue Forecast (2022-2027)
7.2.7 Latin America Personalized Medicines In Oncology Sales Volume and Revenue Forecast (2022-2027)
7.2.8 Middle East and Africa Personalized Medicines In Oncology Sales Volume and Revenue Forecast (2022-2027)
7.3 Global Personalized Medicines In Oncology Sales Volume, Revenue and Price Forecast by Type (2022-2027)
7.3.1 Global Personalized Medicines In Oncology Revenue and Growth Rate of Molecular Oncopathology (2022-2027)
7.3.2 Global Personalized Medicines In Oncology Revenue and Growth Rate of Genome Diagnostics (2022-2027)
7.3.3 Global Personalized Medicines In Oncology Revenue and Growth Rate of Radiation Therapy (2022-2027)
7.3.4 Global Personalized Medicines In Oncology Revenue and Growth Rate of Oncology Testing (2022-2027)
7.3.5 Global Personalized Medicines In Oncology Revenue and Growth Rate of Chemotherapy (2022-2027)
7.3.6 Global Personalized Medicines In Oncology Revenue and Growth Rate of Others (2022-2027)
7.4 Global Personalized Medicines In Oncology Consumption Forecast by Application (2022-2027)
7.4.1 Global Personalized Medicines In Oncology Consumption Value and Growth Rate of Research Centers(2022-2027)
7.4.2 Global Personalized Medicines In Oncology Consumption Value and Growth Rate of Governmental Institutions(2022-2027)
7.4.3 Global Personalized Medicines In Oncology Consumption Value and Growth Rate of Hospitals(2022-2027)
7.4.4 Global Personalized Medicines In Oncology Consumption Value and Growth Rate of Clinical Centers(2022-2027)
7.4.5 Global Personalized Medicines In Oncology Consumption Value and Growth Rate of Others(2022-2027)
7.5 Personalized Medicines In Oncology Market Forecast Under COVID-19
8 PERSONALIZED MEDICINES IN ONCOLOGY MARKET UPSTREAM AND DOWNSTREAM ANALYSIS
8.1 Personalized Medicines In Oncology Industrial Chain Analysis
8.2 Key Raw Materials Suppliers and Price Analysis
8.3 Manufacturing Cost Structure Analysis
8.3.1 Labor Cost Analysis
8.3.2 Energy Costs Analysis
8.3.3 R&D Costs Analysis
8.4 Alternative Product Analysis
8.5 Major Distributors of Personalized Medicines In Oncology Analysis
8.6 Major Downstream Buyers of Personalized Medicines In Oncology Analysis
8.7 Impact of COVID-19 and the Russia-Ukraine war on the Upstream and Downstream in the Personalized Medicines In Oncology Industry
9 PLAYERS PROFILES
9.1 Genomic Health, Inc.(Exact Sciences)
9.1.1 Genomic Health, Inc.(Exact Sciences) Basic Information, Manufacturing Base, Sales Region and Competitors
9.1.2 Personalized Medicines In Oncology Product Profiles, Application and Specification
9.1.3 Genomic Health, Inc.(Exact Sciences) Market Performance (2017-2022)
9.1.4 Recent Development
9.1.5 SWOT Analysis
9.2 Illumina
9.2.1 Illumina Basic Information, Manufacturing Base, Sales Region and Competitors
9.2.2 Personalized Medicines In Oncology Product Profiles, Application and Specification
9.2.3 Illumina Market Performance (2017-2022)
9.2.4 Recent Development
9.2.5 SWOT Analysis
9.3 Caris Life Sciences
9.3.1 Caris Life Sciences Basic Information, Manufacturing Base, Sales Region and Competitors
9.3.2 Personalized Medicines In Oncology Product Profiles, Application and Specification
9.3.3 Caris Life Sciences Market Performance (2017-2022)
9.3.4 Recent Development
9.3.5 SWOT Analysis
9.4 Cypher Genomics(Human Longevity, Inc.)
9.4.1 Cypher Genomics(Human Longevity, Inc.) Basic Information, Manufacturing Base, Sales Region and Competitors
9.4.2 Personalized Medicines In Oncology Product Profiles, Application and Specification
9.4.3 Cypher Genomics(Human Longevity, Inc.) Market Performance (2017-2022)
9.4.4 Recent Development
9.4.5 SWOT Analysis
9.5 Biotheranostics
9.5.1 Biotheranostics Basic Information, Manufacturing Base, Sales Region and Competitors
9.5.2 Personalized Medicines In Oncology Product Profiles, Application and Specification
9.5.3 Biotheranostics Market Performance (2017-2022)
9.5.4 Recent Development
9.5.5 SWOT Analysis
9.6 Life Technologies Corporation(Thermo Fisher Scientific)
9.6.1 Life Technologies Corporation(Thermo Fisher Scientific) Basic Information, Manufacturing Base, Sales Region and Competitors
9.6.2 Personalized Medicines In Oncology Product Profiles, Application and Specification
9.6.3 Life Technologies Corporation(Thermo Fisher Scientific) Market Performance (2017-2022)
9.6.4 Recent Development
9.6.5 SWOT Analysis
9.7 Ariana Pharma
9.7.1 Ariana Pharma Basic Information, Manufacturing Base, Sales Region and Competitors
9.7.2 Personalized Medicines In Oncology Product Profiles, Application and Specification
9.7.3 Ariana Pharma Market Performance (2017-2022)
9.7.4 Recent Development
9.7.5 SWOT Analysis
9.8 Fulgent Genetics
9.8.1 Fulgent Genetics Basic Information, Manufacturing Base, Sales Region and Competitors
9.8.2 Personalized Medicines In Oncology Product Profiles, Application and Specification
9.8.3 Fulgent Genetics Market Performance (2017-2022)
9.8.4 Recent Development
9.8.5 SWOT Analysis
9.9 DNA Link
9.9.1 DNA Link Basic Information, Manufacturing Base, Sales Region and Competitors
9.9.2 Personalized Medicines In Oncology Product Profiles, Application and Specification
9.9.3 DNA Link Market Performance (2017-2022)
9.9.4 Recent Development
9.9.5 SWOT Analysis
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Data Source
LIST OF TABLES AND FIGURES
Figure Personalized Medicines In Oncology Product Picture
Table Global Personalized Medicines In Oncology Market Sales Volume and CAGR (%) Comparison by Type
Table Personalized Medicines In Oncology Market Consumption (Sales Volume) Comparison by Application (2017-2027)
Figure Global Personalized Medicines In Oncology Market Size (Revenue, Million USD) and CAGR (%) (2017-2027)
Figure United States Personalized Medicines In Oncology Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Europe Personalized Medicines In Oncology Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure China Personalized Medicines In Oncology Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Japan Personalized Medicines In Oncology Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure India Personalized Medicines In Oncology Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Southeast Asia Personalized Medicines In Oncology Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Latin America Personalized Medicines In Oncology Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Middle East and Africa Personalized Medicines In Oncology Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Global Personalized Medicines In Oncology Market Sales Volume Status and Outlook (2017-2027)
Table Global Macroeconomic Analysis
Figure Global COVID-19 Status Overview
Table Influence of COVID-19 Outbreak on Personalized Medicines In Oncology Industry Development
Table Global Personalized Medicines In Oncology Sales Volume by Player (2017-2022)
Table Global Personalized Medicines In Oncology Sales Volume Share by Player (2017-2022)
Figure Global Personalized Medicines In Oncology Sales Volume Share by Player in 2021
Table Personalized Medicines In Oncology Revenue (Million USD) by Player (2017-2022)
Table Personalized Medicines In Oncology Revenue Market Share by Player (2017-2022)
Table Personalized Medicines In Oncology Price by Player (2017-2022)
Table Personalized Medicines In Oncology Gross Margin by Player (2017-2022)
Table Mergers & Acquisitions, Expansion Plans
Table Global Personalized Medicines In Oncology Sales Volume, Region Wise (2017-2022)
Table Global Personalized Medicines In Oncology Sales Volume Market Share, Region Wise (2017-2022)
Figure Global Personalized Medicines In Oncology Sales Volume Market Share, Region Wise (2017-2022)
Figure Global Personalized Medicines In Oncology Sales Volume Market Share, Region Wise in 2021
Table Global Personalized Medicines In Oncology Revenue (Million USD), Region Wise (2017-2022)
Table Global Personalized Medicines In Oncology Revenue Market Share, Region Wise (2017-2022)
Figure Global Personalized Medicines In Oncology Revenue Market Share, Region Wise (2017-2022)
Figure Global Personalized Medicines In Oncology Revenue Market Share, Region Wise in 2021
Table Global Personalized Medicines In Oncology Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table United States Personalized Medicines In Oncology Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Europe Personalized Medicines In Oncology Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table China Personalized Medicines In Oncology Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Japan Personalized Medicines In Oncology Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table India Personalized Medicines In Oncology Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Southeast Asia Personalized Medicines In Oncology Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Latin America Personalized Medicines In Oncology Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Middle East and Africa Personalized Medicines In Oncology Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Global Personalized Medicines In Oncology Sales Volume by Type (2017-2022)
Table Global Personalized Medicines In Oncology Sales Volume Market Share by Type (2017-2022)
Figure Global Personalized Medicines In Oncology Sales Volume Market Share by Type in 2021
Table Global Personalized Medicines In Oncology Revenue (Million USD) by Type (2017-2022)
Table Global Personalized Medicines In Oncology Revenue Market Share by Type (2017-2022)
Figure Global Personalized Medicines In Oncology Revenue Market Share by Type in 2021
Table Personalized Medicines In Oncology Price by Type (2017-2022)
Figure Global Personalized Medicines In Oncology Sales Volume and Growth Rate of Molecular Oncopathology (2017-2022)
Figure Global Personalized Medicines In Oncology Revenue (Million USD) and Growth Rate of Molecular Oncopathology (2017-2022)
Figure Global Personalized Medicines In Oncology Sales Volume and Growth Rate of Genome Diagnostics (2017-2022)
Figure Global Personalized Medicines In Oncology Revenue (Million USD) and Growth Rate of Genome Diagnostics (2017-2022)
Figure Global Personalized Medicines In Oncology Sales Volume and Growth Rate of Radiation Therapy (2017-2022)
Figure Global Personalized Medicines In Oncology Revenue (Million USD) and Growth Rate of Radiation Therapy (2017-2022)
Figure Global Personalized Medicines In Oncology Sales Volume and Growth Rate of Oncology Testing (2017-2022)
Figure Global Personalized Medicines In Oncology Revenue (Million USD) and Growth Rate of Oncology Testing (2017-2022)
Figure Global Personalized Medicines In Oncology Sales Volume and Growth Rate of Chemotherapy (2017-2022)
Figure Global Personalized Medicines In Oncology Revenue (Million USD) and Growth Rate of Chemotherapy (2017-2022)
Figure Global Personalized Medicines In Oncology Sales Volume and Growth Rate of Others (2017-2022)
Figure Global Personalized Medicines In Oncology Revenue (Million USD) and Growth Rate of Others (2017-2022)
Table Global Personalized Medicines In Oncology Consumption by Application (2017-2022)
Table Global Personalized Medicines In Oncology Consumption Market Share by Application (2017-2022)
Table Global Personalized Medicines In Oncology Consumption Revenue (Million USD) by Application (2017-2022)
Table Global Personalized Medicines In Oncology Consumption Revenue Market Share by Application (2017-2022)
Table Global Personalized Medicines In Oncology Consumption and Growth Rate of Research Centers (2017-2022)
Table Global Personalized Medicines In Oncology Consumption and Growth Rate of Governmental Institutions (2017-2022)
Table Global Personalized Medicines In Oncology Consumption and Growth Rate of Hospitals (2017-2022)
Table Global Personalized Medicines In Oncology Consumption and Growth Rate of Clinical Centers (2017-2022)
Table Global Personalized Medicines In Oncology Consumption and Growth Rate of Others (2017-2022)
Figure Global Personalized Medicines In Oncology Sales Volume and Growth Rate Forecast (2022-2027)
Figure Global Personalized Medicines In Oncology Revenue (Million USD) and Growth Rate Forecast (2022-2027)
Figure Global Personalized Medicines In Oncology Price and Trend Forecast (2022-2027)
Figure USA Personalized Medicines In Oncology Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure USA Personalized Medicines In Oncology Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Europe Personalized Medicines In Oncology Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Europe Personalized Medicines In Oncology Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure China Personalized Medicines In Oncology Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure China Personalized Medicines In Oncology Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Japan Personalized Medicines In Oncology Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Japan Personalized Medicines In Oncology Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure India Personalized Medicines In Oncology Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure India Personalized Medicines In Oncology Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Southeast Asia Personalized Medicines In Oncology Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Southeast Asia Personalized Medicines In Oncology Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Latin America Personalized Medicines In Oncology Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Latin America Personalized Medicines In Oncology Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Middle East and Africa Personalized Medicines In Oncology Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Middle East and Africa Personalized Medicines In Oncology Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Table Global Personalized Medicines In Oncology Market Sales Volume Forecast, by Type
Table Global Personalized Medicines In Oncology Sales Volume Market Share Forecast, by Type
Table Global Personalized Medicines In Oncology Market Revenue (Million USD) Forecast, by Type
Table Global Personalized Medicines In Oncology Revenue Market Share Forecast, by Type
Table Global Personalized Medicines In Oncology Price Forecast, by Type
Figure Global Personalized Medicines In Oncology Revenue (Million USD) and Growth Rate of Molecular Oncopathology (2022-2027)
Figure Global Personalized Medicines In Oncology Revenue (Million USD) and Growth Rate of Molecular Oncopathology (2022-2027)
Figure Global Personalized Medicines In Oncology Revenue (Million USD) and Growth Rate of Genome Diagnostics (2022-2027)
Figure Global Personalized Medicines In Oncology Revenue (Million USD) and Growth Rate of Genome Diagnostics (2022-2027)
Figure Global Personalized Medicines In Oncology Revenue (Million USD) and Growth Rate of Radiation Therapy (2022-2027)
Figure Global Personalized Medicines In Oncology Revenue (Million USD) and Growth Rate of Radiation Therapy (2022-2027)
Figure Global Personalized Medicines In Oncology Revenue (Million USD) and Growth Rate of Oncology Testing (2022-2027)
Figure Global Personalized Medicines In Oncology Revenue (Million USD) and Growth Rate of Oncology Testing (2022-2027)
Figure Global Personalized Medicines In Oncology Revenue (Million USD) and Growth Rate of Chemotherapy (2022-2027)
Figure Global Personalized Medicines In Oncology Revenue (Million USD) and Growth Rate of Chemotherapy (2022-2027)
Figure Global Personalized Medicines In Oncology Revenue (Million USD) and Growth Rate of Others (2022-2027)
Figure Global Personalized Medicines In Oncology Revenue (Million USD) and Growth Rate of Others (2022-2027)
Table Global Personalized Medicines In Oncology Market Consumption Forecast, by Application
Table Global Personalized Medicines In Oncology Consumption Market Share Forecast, by Application
Table Global Personalized Medicines In Oncology Market Revenue (Million USD) Forecast, by Application
Table Global Personalized Medicines In Oncology Revenue Market Share Forecast, by Application
Figure Global Personalized Medicines In Oncology Consumption Value (Million USD) and Growth Rate of Research Centers (2022-2027)
Figure Global Personalized Medicines In Oncology Consumption Value (Million USD) and Growth Rate of Governmental Institutions (2022-2027)
Figure Global Personalized Medicines In Oncology Consumption Value (Million USD) and Growth Rate of Hospitals (2022-2027)
Figure Global Personalized Medicines In Oncology Consumption Value (Million USD) and Growth Rate of Clinical Centers (2022-2027)
Figure Global Personalized Medicines In Oncology Consumption Value (Million USD) and Growth Rate of Others (2022-2027)
Figure Personalized Medicines In Oncology Industrial Chain Analysis
Table Key Raw Materials Suppliers and Price Analysis
Figure Manufacturing Cost Structure Analysis
Table Alternative Product Analysis
Table Downstream Distributors
Table Downstream Buyers
Table Genomic Health, Inc.(Exact Sciences) Profile
Table Genomic Health, Inc.(Exact Sciences) Personalized Medicines In Oncology Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Genomic Health, Inc.(Exact Sciences) Personalized Medicines In Oncology Sales Volume and Growth Rate
Figure Genomic Health, Inc.(Exact Sciences) Revenue (Million USD) Market Share 2017-2022
Table Illumina Profile
Table Illumina Personalized Medicines In Oncology Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Illumina Personalized Medicines In Oncology Sales Volume and Growth Rate
Figure Illumina Revenue (Million USD) Market Share 2017-2022
Table Caris Life Sciences Profile
Table Caris Life Sciences Personalized Medicines In Oncology Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Caris Life Sciences Personalized Medicines In Oncology Sales Volume and Growth Rate
Figure Caris Life Sciences Revenue (Million USD) Market Share 2017-2022
Table Cypher Genomics(Human Longevity, Inc.) Profile
Table Cypher Genomics(Human Longevity, Inc.) Personalized Medicines In Oncology Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Cypher Genomics(Human Longevity, Inc.) Personalized Medicines In Oncology Sales Volume and Growth Rate
Figure Cypher Genomics(Human Longevity, Inc.) Revenue (Million USD) Market Share 2017-2022
Table Biotheranostics Profile
Table Biotheranostics Personalized Medicines In Oncology Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Biotheranostics Personalized Medicines In Oncology Sales Volume and Growth Rate
Figure Biotheranostics Revenue (Million USD) Market Share 2017-2022
Table Life Technologies Corporation(Thermo Fisher Scientific) Profile
Table Life Technologies Corporation(Thermo Fisher Scientific) Personalized Medicines In Oncology Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Life Technologies Corporation(Thermo Fisher Scientific) Personalized Medicines In Oncology Sales Volume and Growth Rate
Figure Life Technologies Corporation(Thermo Fisher Scientific) Revenue (Million USD) Market Share 2017-2022
Table Ariana Pharma Profile
Table Ariana Pharma Personalized Medicines In Oncology Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Ariana Pharma Personalized Medicines In Oncology Sales Volume and Growth Rate
Figure Ariana Pharma Revenue (Million USD) Market Share 2017-2022
Table Fulgent Genetics Profile
Table Fulgent Genetics Personalized Medicines In Oncology Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Fulgent Genetics Personalized Medicines In Oncology Sales Volume and Growth Rate
Figure Fulgent Genetics Revenue (Million USD) Market Share 2017-2022
Table DNA Link Profile
Table DNA Link Personalized Medicines In Oncology Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure DNA Link Personalized Medicines In Oncology Sales Volume and Growth Rate
Figure DNA Link Revenue (Million USD) Market Share 2017-2022
Figure Personalized Medicines In Oncology Product Picture
Table Global Personalized Medicines In Oncology Market Sales Volume and CAGR (%) Comparison by Type
Table Personalized Medicines In Oncology Market Consumption (Sales Volume) Comparison by Application (2017-2027)
Figure Global Personalized Medicines In Oncology Market Size (Revenue, Million USD) and CAGR (%) (2017-2027)
Figure United States Personalized Medicines In Oncology Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Europe Personalized Medicines In Oncology Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure China Personalized Medicines In Oncology Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Japan Personalized Medicines In Oncology Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure India Personalized Medicines In Oncology Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Southeast Asia Personalized Medicines In Oncology Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Latin America Personalized Medicines In Oncology Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Middle East and Africa Personalized Medicines In Oncology Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Global Personalized Medicines In Oncology Market Sales Volume Status and Outlook (2017-2027)
Table Global Macroeconomic Analysis
Figure Global COVID-19 Status Overview
Table Influence of COVID-19 Outbreak on Personalized Medicines In Oncology Industry Development
Table Global Personalized Medicines In Oncology Sales Volume by Player (2017-2022)
Table Global Personalized Medicines In Oncology Sales Volume Share by Player (2017-2022)
Figure Global Personalized Medicines In Oncology Sales Volume Share by Player in 2021
Table Personalized Medicines In Oncology Revenue (Million USD) by Player (2017-2022)
Table Personalized Medicines In Oncology Revenue Market Share by Player (2017-2022)
Table Personalized Medicines In Oncology Price by Player (2017-2022)
Table Personalized Medicines In Oncology Gross Margin by Player (2017-2022)
Table Mergers & Acquisitions, Expansion Plans
Table Global Personalized Medicines In Oncology Sales Volume, Region Wise (2017-2022)
Table Global Personalized Medicines In Oncology Sales Volume Market Share, Region Wise (2017-2022)
Figure Global Personalized Medicines In Oncology Sales Volume Market Share, Region Wise (2017-2022)
Figure Global Personalized Medicines In Oncology Sales Volume Market Share, Region Wise in 2021
Table Global Personalized Medicines In Oncology Revenue (Million USD), Region Wise (2017-2022)
Table Global Personalized Medicines In Oncology Revenue Market Share, Region Wise (2017-2022)
Figure Global Personalized Medicines In Oncology Revenue Market Share, Region Wise (2017-2022)
Figure Global Personalized Medicines In Oncology Revenue Market Share, Region Wise in 2021
Table Global Personalized Medicines In Oncology Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table United States Personalized Medicines In Oncology Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Europe Personalized Medicines In Oncology Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table China Personalized Medicines In Oncology Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Japan Personalized Medicines In Oncology Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table India Personalized Medicines In Oncology Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Southeast Asia Personalized Medicines In Oncology Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Latin America Personalized Medicines In Oncology Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Middle East and Africa Personalized Medicines In Oncology Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Global Personalized Medicines In Oncology Sales Volume by Type (2017-2022)
Table Global Personalized Medicines In Oncology Sales Volume Market Share by Type (2017-2022)
Figure Global Personalized Medicines In Oncology Sales Volume Market Share by Type in 2021
Table Global Personalized Medicines In Oncology Revenue (Million USD) by Type (2017-2022)
Table Global Personalized Medicines In Oncology Revenue Market Share by Type (2017-2022)
Figure Global Personalized Medicines In Oncology Revenue Market Share by Type in 2021
Table Personalized Medicines In Oncology Price by Type (2017-2022)
Figure Global Personalized Medicines In Oncology Sales Volume and Growth Rate of Molecular Oncopathology (2017-2022)
Figure Global Personalized Medicines In Oncology Revenue (Million USD) and Growth Rate of Molecular Oncopathology (2017-2022)
Figure Global Personalized Medicines In Oncology Sales Volume and Growth Rate of Genome Diagnostics (2017-2022)
Figure Global Personalized Medicines In Oncology Revenue (Million USD) and Growth Rate of Genome Diagnostics (2017-2022)
Figure Global Personalized Medicines In Oncology Sales Volume and Growth Rate of Radiation Therapy (2017-2022)
Figure Global Personalized Medicines In Oncology Revenue (Million USD) and Growth Rate of Radiation Therapy (2017-2022)
Figure Global Personalized Medicines In Oncology Sales Volume and Growth Rate of Oncology Testing (2017-2022)
Figure Global Personalized Medicines In Oncology Revenue (Million USD) and Growth Rate of Oncology Testing (2017-2022)
Figure Global Personalized Medicines In Oncology Sales Volume and Growth Rate of Chemotherapy (2017-2022)
Figure Global Personalized Medicines In Oncology Revenue (Million USD) and Growth Rate of Chemotherapy (2017-2022)
Figure Global Personalized Medicines In Oncology Sales Volume and Growth Rate of Others (2017-2022)
Figure Global Personalized Medicines In Oncology Revenue (Million USD) and Growth Rate of Others (2017-2022)
Table Global Personalized Medicines In Oncology Consumption by Application (2017-2022)
Table Global Personalized Medicines In Oncology Consumption Market Share by Application (2017-2022)
Table Global Personalized Medicines In Oncology Consumption Revenue (Million USD) by Application (2017-2022)
Table Global Personalized Medicines In Oncology Consumption Revenue Market Share by Application (2017-2022)
Table Global Personalized Medicines In Oncology Consumption and Growth Rate of Research Centers (2017-2022)
Table Global Personalized Medicines In Oncology Consumption and Growth Rate of Governmental Institutions (2017-2022)
Table Global Personalized Medicines In Oncology Consumption and Growth Rate of Hospitals (2017-2022)
Table Global Personalized Medicines In Oncology Consumption and Growth Rate of Clinical Centers (2017-2022)
Table Global Personalized Medicines In Oncology Consumption and Growth Rate of Others (2017-2022)
Figure Global Personalized Medicines In Oncology Sales Volume and Growth Rate Forecast (2022-2027)
Figure Global Personalized Medicines In Oncology Revenue (Million USD) and Growth Rate Forecast (2022-2027)
Figure Global Personalized Medicines In Oncology Price and Trend Forecast (2022-2027)
Figure USA Personalized Medicines In Oncology Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure USA Personalized Medicines In Oncology Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Europe Personalized Medicines In Oncology Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Europe Personalized Medicines In Oncology Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure China Personalized Medicines In Oncology Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure China Personalized Medicines In Oncology Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Japan Personalized Medicines In Oncology Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Japan Personalized Medicines In Oncology Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure India Personalized Medicines In Oncology Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure India Personalized Medicines In Oncology Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Southeast Asia Personalized Medicines In Oncology Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Southeast Asia Personalized Medicines In Oncology Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Latin America Personalized Medicines In Oncology Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Latin America Personalized Medicines In Oncology Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Middle East and Africa Personalized Medicines In Oncology Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Middle East and Africa Personalized Medicines In Oncology Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Table Global Personalized Medicines In Oncology Market Sales Volume Forecast, by Type
Table Global Personalized Medicines In Oncology Sales Volume Market Share Forecast, by Type
Table Global Personalized Medicines In Oncology Market Revenue (Million USD) Forecast, by Type
Table Global Personalized Medicines In Oncology Revenue Market Share Forecast, by Type
Table Global Personalized Medicines In Oncology Price Forecast, by Type
Figure Global Personalized Medicines In Oncology Revenue (Million USD) and Growth Rate of Molecular Oncopathology (2022-2027)
Figure Global Personalized Medicines In Oncology Revenue (Million USD) and Growth Rate of Molecular Oncopathology (2022-2027)
Figure Global Personalized Medicines In Oncology Revenue (Million USD) and Growth Rate of Genome Diagnostics (2022-2027)
Figure Global Personalized Medicines In Oncology Revenue (Million USD) and Growth Rate of Genome Diagnostics (2022-2027)
Figure Global Personalized Medicines In Oncology Revenue (Million USD) and Growth Rate of Radiation Therapy (2022-2027)
Figure Global Personalized Medicines In Oncology Revenue (Million USD) and Growth Rate of Radiation Therapy (2022-2027)
Figure Global Personalized Medicines In Oncology Revenue (Million USD) and Growth Rate of Oncology Testing (2022-2027)
Figure Global Personalized Medicines In Oncology Revenue (Million USD) and Growth Rate of Oncology Testing (2022-2027)
Figure Global Personalized Medicines In Oncology Revenue (Million USD) and Growth Rate of Chemotherapy (2022-2027)
Figure Global Personalized Medicines In Oncology Revenue (Million USD) and Growth Rate of Chemotherapy (2022-2027)
Figure Global Personalized Medicines In Oncology Revenue (Million USD) and Growth Rate of Others (2022-2027)
Figure Global Personalized Medicines In Oncology Revenue (Million USD) and Growth Rate of Others (2022-2027)
Table Global Personalized Medicines In Oncology Market Consumption Forecast, by Application
Table Global Personalized Medicines In Oncology Consumption Market Share Forecast, by Application
Table Global Personalized Medicines In Oncology Market Revenue (Million USD) Forecast, by Application
Table Global Personalized Medicines In Oncology Revenue Market Share Forecast, by Application
Figure Global Personalized Medicines In Oncology Consumption Value (Million USD) and Growth Rate of Research Centers (2022-2027)
Figure Global Personalized Medicines In Oncology Consumption Value (Million USD) and Growth Rate of Governmental Institutions (2022-2027)
Figure Global Personalized Medicines In Oncology Consumption Value (Million USD) and Growth Rate of Hospitals (2022-2027)
Figure Global Personalized Medicines In Oncology Consumption Value (Million USD) and Growth Rate of Clinical Centers (2022-2027)
Figure Global Personalized Medicines In Oncology Consumption Value (Million USD) and Growth Rate of Others (2022-2027)
Figure Personalized Medicines In Oncology Industrial Chain Analysis
Table Key Raw Materials Suppliers and Price Analysis
Figure Manufacturing Cost Structure Analysis
Table Alternative Product Analysis
Table Downstream Distributors
Table Downstream Buyers
Table Genomic Health, Inc.(Exact Sciences) Profile
Table Genomic Health, Inc.(Exact Sciences) Personalized Medicines In Oncology Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Genomic Health, Inc.(Exact Sciences) Personalized Medicines In Oncology Sales Volume and Growth Rate
Figure Genomic Health, Inc.(Exact Sciences) Revenue (Million USD) Market Share 2017-2022
Table Illumina Profile
Table Illumina Personalized Medicines In Oncology Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Illumina Personalized Medicines In Oncology Sales Volume and Growth Rate
Figure Illumina Revenue (Million USD) Market Share 2017-2022
Table Caris Life Sciences Profile
Table Caris Life Sciences Personalized Medicines In Oncology Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Caris Life Sciences Personalized Medicines In Oncology Sales Volume and Growth Rate
Figure Caris Life Sciences Revenue (Million USD) Market Share 2017-2022
Table Cypher Genomics(Human Longevity, Inc.) Profile
Table Cypher Genomics(Human Longevity, Inc.) Personalized Medicines In Oncology Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Cypher Genomics(Human Longevity, Inc.) Personalized Medicines In Oncology Sales Volume and Growth Rate
Figure Cypher Genomics(Human Longevity, Inc.) Revenue (Million USD) Market Share 2017-2022
Table Biotheranostics Profile
Table Biotheranostics Personalized Medicines In Oncology Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Biotheranostics Personalized Medicines In Oncology Sales Volume and Growth Rate
Figure Biotheranostics Revenue (Million USD) Market Share 2017-2022
Table Life Technologies Corporation(Thermo Fisher Scientific) Profile
Table Life Technologies Corporation(Thermo Fisher Scientific) Personalized Medicines In Oncology Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Life Technologies Corporation(Thermo Fisher Scientific) Personalized Medicines In Oncology Sales Volume and Growth Rate
Figure Life Technologies Corporation(Thermo Fisher Scientific) Revenue (Million USD) Market Share 2017-2022
Table Ariana Pharma Profile
Table Ariana Pharma Personalized Medicines In Oncology Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Ariana Pharma Personalized Medicines In Oncology Sales Volume and Growth Rate
Figure Ariana Pharma Revenue (Million USD) Market Share 2017-2022
Table Fulgent Genetics Profile
Table Fulgent Genetics Personalized Medicines In Oncology Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Fulgent Genetics Personalized Medicines In Oncology Sales Volume and Growth Rate
Figure Fulgent Genetics Revenue (Million USD) Market Share 2017-2022
Table DNA Link Profile
Table DNA Link Personalized Medicines In Oncology Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure DNA Link Personalized Medicines In Oncology Sales Volume and Growth Rate
Figure DNA Link Revenue (Million USD) Market Share 2017-2022
